hydrazine and Liposarcoma
hydrazine has been researched along with Liposarcoma in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Alcindor, T; Attia, S; Badalamenti, G; Ben-Shahar, O; Beveridge, RD; Blay, JY; Burgess, M; Chang, H; Chawla, S; Chen, JL; Chevreau, C; Chmielowski, B; Davis, EJ; Deshpande, H; Dickson, MA; Duffaud, F; Elias, A; Eriksson, M; Forscher, C; Ganjoo, KN; Garcia Del Muro, X; Gonzalez, AE; Götze, K; Gounder, MM; Grignani, G; Gröschel, S; Hartner, L; Hatcher, H; Herráez, AC; Italiano, A; Jones, RL; Kasper, B; Kauffman, MG; Landesman, Y; Lapeire, L; Le Cesne, A; Lee, A; Li, L; Liu, J; Loggers, ET; Martin-Broto, J; Mazzeo, F; Meng, C; Meyer, C; Michel, D; Mulcahy, MF; Napolitano, A; Nicholas, G; Okuno, S; Penel, N; Philip, T; Piperno-Neumann, S; Razak, AA; Reichardt, P; Riedel, RF; Ryan, C; Schuetze, SM; Schwartz, GK; Shacham, S; Shah, JJ; Somaiah, N; Stacchiotti, S; Valverde Morales, CM; Van Domelen, DR; Van Tine, BA; Vincenzi, B; von Mehren, M; Wagner, AJ; Walker, CJ; Yakobson, A; Zick, A | 1 |
Dakle, P; Jeitany, M; Jiang, YY; Kanojia, D; Kappei, D; Koeffler, HP; Landesman, Y; Madan, V; Mukundan, V; Pathak, E; Prabhu, A; Tam, WL | 1 |
Barisella, M; Brich, S; Casali, PG; Colombo, C; Dagrada, GP; Dei Tos, AP; El Bezawy, R; Gounder, M; Gronchi, A; Lauricella, C; Pasquali, S; Percio, S; Sanfilippo, R; Stacchiotti, S; Tortoreto, M; Zaffaroni, N; Zuco, V | 1 |
Abdul Razak, AR; Attia, S; Chawla, SP; Chmielowski, B; Gilligan, AM; Gounder, M; Grignani, G; Jones, RL; Kauffman, M; Leong, H; Ma, X; Martin-Broto, J; Riedel, RF; Schuetze, SM; Shacham, S; Shah, J; Somaiah, N; Vincenzi, B; Wagner, AJ | 1 |
Baloglu, E; Chien, W; Chuang, LS; Doan, NB; Ganesan, TS; Garg, M; Kanojia, D; Kauffman, M; Koeffler, HP; Mayakonda, A; Said, JW; Shacham, S; Venkatachalam, N | 1 |
Trials
2 trial(s) available for hydrazine and Liposarcoma
Article | Year |
---|---|
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Child; Double-Blind Method; Humans; Hydrazines; Liposarcoma; Triazoles | 2022 |
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma.
Topics: Adult; Aged; Aged, 80 and over; Cancer Pain; Cross-Over Studies; Female; Humans; Hydrazines; Liposarcoma; Male; Middle Aged; Neoplasm Staging; Placebos; Quality of Life; Triazoles | 2021 |
Other Studies
3 other study(ies) available for hydrazine and Liposarcoma
Article | Year |
---|---|
Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cell Line, Tumor; Cell Nucleus; Drug Resistance, Neoplasm; Drug Synergism; Exportin 1 Protein; Fatty Acid Desaturases; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Karyopherins; Liposarcoma; Oligopeptides; Piperazines; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Receptors, Cytoplasmic and Nuclear; Triazoles | 2021 |
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulation.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Dedifferentiation; Cell Nucleus; Down-Regulation; Doxorubicin; Humans; Hydrazines; Liposarcoma; Male; Mice; Mice, Nude; Random Allocation; Survivin; Triazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2021 |
Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase A; Aurora Kinase B; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Insulin-Like Growth Factor Binding Protein 5; Karyopherins; Liposarcoma; Male; Mice; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptors, Cytoplasmic and Nuclear; Receptors, Somatomedin; RNA Interference; Signal Transduction; Time Factors; Transfection; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |